Pain Therapeutics Wins Grants to Develop Alzheimer's Blood Test and Fentanyl Patch

Pain Therapeutics won two grants worth a total of $4 million from the NIH to support the development of a blood-based diagnostic for Alzheimer’s disease and its fentanyl-based Fenrock™ transdermal patch for treating severe pain.The funding includes a $1.8 million research grant from the National Institute on Aging (NIA), to fund the development of a blood test for Alzheimer’s disease, based on Pain Therapeutics’ clinical-stage PTI-125 drug candidate for Alzheimer’s